Macrogenics logo

Macrogenics Share Price Today

(NASDAQ: MGNX)

Macrogenics share price is $1.26 & ₹107.69 as on 18 Apr 2025, 2.30 'hrs' IST

$1.26

0.08

(6.78%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Macrogenics share price in Dollar and Rupees. Guide to invest in Macrogenics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Macrogenics, along with analyst recommendations, forecasts, and comprehensive financials.

Macrogenics share price movements

  • Today's Low: $1.12
    Today's High: $1.28

    Day's Volatility :12.89%

  • 52 Weeks Low: $0.99
    52 Weeks High: $16.59

    52 Weeks Volatility :94.03%

Macrogenics (MGNX) Returns

PeriodMacrogenics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-58.0%
-2.8%
0.0%
6 Months
-67.36%
-11.0%
0.0%
1 Year
-91.93%
-1.9%
0.0%
3 Years
-83.78%
-1.5%
-12.9%

Macrogenics (MGNX) Key Statistics

in dollars & INR

Previous Close
$1.18
Open
$1.2
Today's High
$1.28
Today's Low
$1.115
Market Capitalization
$79.5M
Today's Volume
$759.7K
52 Week High
$16.585
52 Week Low
$0.98965
Revenue TTM
$150.0M
EBITDA
$-103.0M
Earnings Per Share (EPS)
$-1.07
Profit Margin
-44.65%
Quarterly Earnings Growth YOY
2.21%
Return On Equity TTM
-49.85%

How to invest in Macrogenics Stock (MGNX) from India?

It is very easy for Indian residents to invest directly in Macrogenics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Macrogenics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Macrogenics or MGNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Macrogenics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Macrogenics shares which would translate to 0.678 fractional shares of Macrogenics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Macrogenics, in just a few clicks!

Returns in Macrogenics (MGNX) for Indian investors in Rupees

The Macrogenics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Macrogenics investment value today

Current value as on today

₹10,413

Returns

₹89,587

(-89.59%)

Returns from Macrogenics Stock

₹91,928 (-91.93%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Macrogenics (MGNX)

88%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Macrogenics Stock from India on INDmoney has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Macrogenics

  • Bellevue Group AG

    15.74%

  • Armistice Capital, LLC

    9.95%

  • BlackRock Inc

    8.02%

  • Vanguard Group Inc

    6.84%

  • Wasatch Advisors LP

    5.53%

  • Millennium Management LLC

    4.54%

Analyst Recommendation on Macrogenics

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Macrogenics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Macrogenics Stock (MGNX)

What analysts predicted

Upside of 360.32%

Target:

$5.80

Current:

$1.26

Insights on Macrogenics Stock (Ticker Symbol: MGNX)

  • Price Movement

    In the last 7 days, MGNX stock has moved down by -8.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 110.70M → 17.73M (in $), with an average decrease of 84.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 56.30M → -15.42M (in $), with an average decrease of 127.4% per quarter
  • MGNX vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 168.5%
  • MGNX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 114.5%
  • Price to Sales

    ForMGNX every $1 of sales, investors are willing to pay $0.5, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Macrogenics Technicals Summary

Sell

Neutral

Buy

Macrogenics is currently in a neutral trading position according to technical analysis indicators.

Macrogenics (MGNX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Macrogenics, Inc. logo
-43.81%
-67.36%
-91.93%
-83.78%
-82.0%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Macrogenics

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.
Organization
Macrogenics
Employees
341
CEO
Dr. Scott Koenig M.D., Ph.D.
Industry
Health Technology

Management People of Macrogenics

NameTitle
Dr. Scott Koenig M.D., Ph.D.
President, CEO & Director
Mr. James Karrels
Senior VP, CFO & Corporate Secretary
Dr. Stephen L. Eck M.D., Ph.D.
Senior VP of Clinical Development & Chief Medical Officer
Mr. Eric Blasius Risser
Chief Operating Officer
Dr. Thomas M. Spitznagel Ph.D.
Senior Vice President of Technical Operations
Dr. Ezio Bonvini M.D.
Senior VP of Research & Chief Scientific Officer
Mr. Jeffrey Stuart Peters J.D.
Senior VP, General Counsel & Corporate Compliance Officer

Important FAQs about investing in MGNX Stock from India :

What is Macrogenics share price today?

Macrogenics share price today stands at $1.26, Open: $1.20 ; Previous Close: $1.18 ; High: $1.28 ; Low: $1.12 ; 52 Week High: $16.59 ; 52 Week Low: $0.99.

The stock opens at $1.20, after a previous close of $1.18. The stock reached a daily high of $1.28 and a low of $1.12, with a 52-week high of $16.59 and a 52-week low of $0.99.

Can Indians buy Macrogenics shares?

Yes, Indians can invest in the Macrogenics (MGNX) from India.

With INDmoney, you can buy Macrogenics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Macrogenics at zero transaction cost.

How can I buy Macrogenics shares from India?

It is very easy to buy Macrogenics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Macrogenics (MGNX) be purchased?

Yes, you can buy fractional shares of Macrogenics with INDmoney app.

What are the documents required to start investing in Macrogenics stocks?

To start investing in Macrogenics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Macrogenics Stock (MGNX)?

Today’s highest price of Macrogenics (MGNX) is $1.28.

Today’s lowest price of Macrogenics (MGNX) is $1.12.

What is today's market capitalisation of Macrogenics?

Today's market capitalisation of Macrogenics MGNX is 79.5M

What is the 52 Week High and Low Range of Macrogenics Stock (MGNX)?

  • 52 Week High

    $16.59

  • 52 Week Low

    $0.99

What are the historical returns of Macrogenics (MGNX)?

  • 1 Month Returns

    -43.81%

  • 3 Months Returns

    -67.36%

  • 1 Year Returns

    -91.93%

  • 5 Years Returns

    -82%

Who is the Chief Executive Officer (CEO) of Macrogenics ?

Dr. Scott Koenig M.D., Ph.D. is the current Chief Executive Officer (CEO) of Macrogenics.